Sign in Subscribe
Class action lawsuits

Class Action Lawsuit Against Alto Neuroscience for Securities Violations

Strategic Insights

— 1 min read

Alto Neuroscience, a biotech company specializing in innovative treatments for neurological disorders, has been accused of making false and misleading statements to the market regarding the effectiveness of its flagship product, ALTO-100, for the treatment of major depressive disorder (MDD). Shareholders who purchased shares during the company's initial public offering (IPO) on February 2, 2024, and between February 2, 2024, and October 22, 2024, are encouraged to contact the law firm DJS Law Group to participate in a potential class action lawsuit.

Key Takeaways:

  • The class action lawsuit alleges that Alto Neuroscience overstated the effectiveness of ALTO-100 for the treatment of MDD, deceiving investors and potentially harming shareholders.
  • The lawsuit claims that the company's offering documents and public statements were false and misleading throughout the offering period, which began on February 2, 2024, and ended on October 22, 2024.
  • Shareholders who suffered losses as a result of these alleged violations are encouraged to contact DJS Law Group to participate in the case, with no cost or obligation.
  • The law firm specializes in securities class actions, corporate governance litigation, and international M&A appraisals, with clients including large and sophisticated hedge funds and alternative asset managers.
  • The lawsuit aims to recover losses suffered by shareholders as a result of Alto Neuroscience's alleged securities violations.
  • DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy.

Statistics:

  • Class period: February 2, 2024, and October 22, 2024
  • IPO date: February 2, 2024
  • Deadline for shareholder registration: September 19, 2025
  • Total potential value of claimed losses: not specified

Sources:

  • [1]\[https://www.djslawllp.com/class-action-litigation/alto-neuroscience-inc/](https://www.djslawllp.com/class-action-litigation/alto-neuroscience-inc/)
  • [2]Contact: David J. Schwartz, DJS Law Group, 274 White Plains Road, Suite 1, Eastchester, NY 10709, Phone: 914-206-9742, Email: David@djslawllp.com

Read more